Novo Nordisk successfully prices Euro medium term notes worth EUR 1.3bn

The proceeds will be used for general corporate purposes, including the refinancing of a bridge loan.
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Novo Nordisk has successfully priced EUR 1.3bn (USD 1.6bn) notes, according to a press release published on Thursday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading